Literature DB >> 308689

Nature and incidence of liver involvement in agnogenic myeloid metaplasia.

M Ligumski, A Polliack, J Benbassat.   

Abstract

Entities:  

Mesh:

Year:  1978        PMID: 308689     DOI: 10.1111/j.1600-0609.1978.tb02497.x

Source DB:  PubMed          Journal:  Scand J Haematol        ISSN: 0036-553X


× No keyword cloud information.
  5 in total

1.  Synergism between hepatocellular injury and shunting in portosystemic encephalopathy (PSE): case report of acute brittle TIPS-induced PSE.

Authors:  Gil Weitzman; Neil J Schamberg; Gerond Lake-Bakaar
Journal:  Dig Dis Sci       Date:  2007-07-20       Impact factor: 3.199

2.  Clinical features of patients with Philadelphia-negative myeloproliferative neoplasms complicated by portal hypertension.

Authors:  Matthew Yan; Holly Geyer; Ruben Mesa; Ehab Atallah; Jeannie Callum; Justyna Bartoszko; Karen Yee; Manjula Maganti; Florence Wong; Vikas Gupta
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2014-06-11

3.  Multicenter analysis of the use of transjugular intrahepatic portosystemic shunt for management of MPN-associated portal hypertension.

Authors:  Christopher R Reilly; Daria V Babushok; Karlyn Martin; Jerry L Spivak; Michael Streiff; Ranjeeta Bahirwani; Jeffrey Mondschein; Brady Stein; Alison Moliterno; Elizabeth O Hexner
Journal:  Am J Hematol       Date:  2017-07-26       Impact factor: 10.047

4.  Portal hypertension secondary to myelofibrosis with myeloid metaplasia: a study of 13 cases.

Authors:  Mohannad Abu-Hilal; Jayant Tawaker
Journal:  World J Gastroenterol       Date:  2009-07-07       Impact factor: 5.742

5.  Myelofibrosis and Portal Hypertension: The Case for Primary Variceal Screening.

Authors:  Marc Samuel Sherman; Wesley R Samore; Daniel Stephan Pratt
Journal:  ACG Case Rep J       Date:  2020-03-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.